 |
|
 |
Welcome to Viralytics
Viralytics is a leading anti-cancer biotechnology company.
Viralytics has acquired, by licence, an anti-cancer virotherapy technology using the naturally occurring Coxsackievirus and Echovirus. With the acquisition; Viralytics’s focus is now a leading anti-cancer biotech with a worldwide outlook.
Viralytics adds value to its projects and investments through its strong business skills, its expertise in project and IP management and its strong experience in business development.
A strong management team, complemented by an experienced Board of Directors manages and controls this process.
|
|
|
|
